{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:14:54Z","timestamp":1793931294221,"version":"4.8.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.biopha.2022.112878","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T18:14:53Z","timestamp":1648577693000},"page":"112878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["From ancient leech to direct thrombin inhibitors and beyond: New from old"],"prefix":"10.1016","volume":"149","author":[{"given":"Maria Rosa","family":"Montinari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Minelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2022.112878_bib1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global burden of thrombosis: epidemiologic aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12959-020-00248-5","article-title":"Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"18","author":"Boonyawat","year":"2020","journal-title":"Thromb. J."},{"key":"10.1016\/j.biopha.2022.112878_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106918","article-title":"Eighty years of oral anticoagulation: Learning from history","volume":"141","author":"Montinari","year":"2021","journal-title":"Vasc. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2022.112878_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0025727300005391","article-title":"Re-imagining bleeders: the medical leech in the nineteenth century bloodletting encounter","volume":"55","author":"Kirk","year":"2011","journal-title":"Med. Hist."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib5","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-109-5-399","article-title":"The medicinal leech. A page from the annelids of internal medicine","volume":"109","author":"Adams","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.biopha.2022.112878_bib6","article-title":"Nicandrea: Theriaca et Alexipharmaca: Sumptibus et typis B.G","author":"Schneider","year":"1856","journal-title":"Teubneri"},{"key":"10.1016\/j.biopha.2022.112878_bib7","unstructured":"Aurelianus CDIES: On acute diseases and On chronic diseases. [Chicago: Univ. of Chicago Press; 1950."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0266-4356(03)00242-0","article-title":"Historical Article: Hirudo medicinalis: ancient origins of, and trends in the use of medicinal leeches throughout history","volume":"42","author":"Whitaker","year":"2004","journal-title":"Br. J. Oral. Maxillofac. Surg."},{"issue":"9","key":"10.1016\/j.biopha.2022.112878_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1445-5994.2009.01965.x","article-title":"Medicinal use of leeches in the texts of ancient Greek, Roman and early Byzantine writers","volume":"39","author":"Papavramidou","year":"2009","journal-title":"Intern Med J."},{"key":"10.1016\/j.biopha.2022.112878_bib10","unstructured":"Galen, K.G. K\u00fcHn,\u00a0F.W. Assmann, V. Nutton. Claudii Galen. Opera omnia Book 11 1821."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s002680010141","article-title":"The leech and the physician: biology, etymology, and medical practice with Hirudinea medicinalis","volume":"24","author":"Mory","year":"2000","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0268-960X(96)90000-4","article-title":"The role of the leech in medical therapeutics","volume":"10","author":"Eldor","year":"1996","journal-title":"Blood Rev."},{"key":"10.1016\/j.biopha.2022.112878_bib13","unstructured":"Avicenna GOC: A treatise on the canon of medicine of Avicenna, incorporating a translation of the first book. [Edited and translated by O Cameron Gruner. New York: Kelley; 1970."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib14","first-page":"127","article-title":"Leech therapeutic applications","volume":"75","author":"Abdualkader","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2022.112878_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/jpc.12701","article-title":"The much maligned leech","volume":"50","author":"Isaacs","year":"2014","journal-title":"J. Paediatr. Child Health"},{"issue":"6","key":"10.1016\/j.biopha.2022.112878_bib16","first-page":"1051","article-title":"The history of the salento\u2019s mental hospital and the use of somatic therapies","volume":"33","author":"Montinari","year":"2017","journal-title":"Acta Med. Mediterr."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib17","first-page":"3","article-title":"The history of leeching and hirudin","volume":"21","author":"Fields","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.biopha.2022.112878_bib18","series-title":"Biotherapy - History, Principles and Practice: A Practical Guide to the Diagnosis and Treatment of Disease using Living Organisms","author":"Grassberger","year":"2013"},{"issue":"3","key":"10.1016\/j.biopha.2022.112878_bib19","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S0002-9270(01)02228-6","article-title":"Leech jar","volume":"96","author":"Kravetz","year":"2001","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.biopha.2022.112878_bib20","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.1969.03160230057018","article-title":"Victor Broussais (1772-1838). System of physiological medicine","volume":"209","author":"Fran\u00e7ois","year":"1969","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.biopha.2022.112878_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/000313480006600318","article-title":"The medicinal leech: past and present","volume":"66","author":"Upshaw","year":"2000","journal-title":"Am. Surg."},{"key":"10.1016\/j.biopha.2022.112878_bib22","series-title":"Modern Surgery: General and Operative","first-page":"73","article-title":"Inflammation","author":"Da Costa","year":"1907"},{"key":"10.1016\/j.biopha.2022.112878_bib23","series-title":"Medicine of the Paris Hospital 1794\u20131848","first-page":"70","author":"Ackerknecht","year":"1967"},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1445-2197.1998.tb02086.x","article-title":"Leeches in medicine","volume":"68","author":"Thearle","year":"1998","journal-title":"Aust. N. Z. J. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00001721-199102000-00028","article-title":"The use of medicinal leeches in microsurgery","volume":"2","author":"Valauri","year":"1991","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.biopha.2022.112878_bib26","first-page":"27","article-title":"History of medicinal leeching and early medical references","author":"Payton","year":"1981","journal-title":"Neurobiol. Leech"},{"key":"10.1016\/j.biopha.2022.112878_bib27","first-page":"322","article-title":"Premium for breeding leeches","volume":"12","author":"Shurtleff","year":"1835","journal-title":"Boston Med. Surg."},{"issue":"3","key":"10.1016\/j.biopha.2022.112878_bib28","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/014107680609900322","article-title":"Pierre-Charles-Alexandre Louis and the evaluation of bloodletting","volume":"99","author":"Morabia","year":"2006","journal-title":"J. R. Soc. Med."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bjps.2003.12.016","article-title":"Hirudo medicinalis and the plastic surgeon","volume":"57","author":"Whitaker","year":"2004","journal-title":"Br. J. Plast. Surg."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib30","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1097\/SCS.0000000000007111","article-title":"Leech Therapy for Complex Facial Lacerations","volume":"32","author":"Cohn","year":"2021","journal-title":"J. Craniofac Surg."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8050099","article-title":"European Medicinal Leeches-New Roles in Modern Medicine","volume":"8","author":"Lemke","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.biopha.2022.112878_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF01833843","article-title":"Ueber die Einwirkung eines Secretes des officinellen Blutegels auf die Gerinnbarkeit des Blutes","volume":"18","author":"Haycraft","year":"1884","journal-title":"Arch. f\u00fcr Exp. Pathol. und Pharmakol."},{"key":"10.1016\/j.biopha.2022.112878_bib33","article-title":"Versuche \u00fcber Transfusion mit dem von Blutegeln gesogenen Blute und \u00fcber die Verwendung frisch bereiteten Egeldecoctes zur Transfusion","author":"Blobel","year":"1892","journal-title":"Druck V. J. Abel"},{"key":"10.1016\/j.biopha.2022.112878_bib34","first-page":"1786","article-title":"\u00dcber Hirudin","volume":"33","author":"Jacobj","year":"1904","journal-title":"Dtsch Med Woche"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02321003","article-title":"Die chemie der blutgerinnung","volume":"4","author":"Morawitz","year":"1905","journal-title":"Ergeb. der Physiol."},{"key":"10.1016\/j.biopha.2022.112878_bib36","first-page":"2203","article-title":"\u00dcber die Bedeutung des Blutegelextraktes f\u00fcr die Therapie der Eklampsie","volume":"43","author":"Engelmann","year":"1909","journal-title":"M\u00fcnch Med Woche"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1160\/TH07-05-0364","article-title":"Hirudin--the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond. A historical piece","volume":"98","author":"Nowak","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF00245864","article-title":"Studies on the mechanism of the anticoagulant effect of hirudin","volume":"229","author":"Markwardt","year":"1956","journal-title":"Naunyn-Schmiede Arch. fur Exp. Pathol. und Pharmakol."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0014-5793(84)80165-9","article-title":"The complete amino acid sequence of hirudin, a thrombin specific inhibitor: application of colour carboxymethylation","volume":"165","author":"Dodt","year":"1984","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.biopha.2022.112878_bib40","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/j.1460-2075.1990.tb07410.x","article-title":"Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition","volume":"9","author":"Gr\u00fctter","year":"1990","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib41","first-page":"379","article-title":"The complete covalent structure of hirudin. Localization of the disulfide bonds","volume":"366","author":"Dodt","year":"1985","journal-title":"Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-2002-35292","article-title":"Hirudin as alternative anticoagulant--a historical review","volume":"28","author":"Markwardt","year":"2002","journal-title":"Semin Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib43","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mam.2008.01.001","article-title":"Thrombin","volume":"29","author":"Di Cera","year":"2008","journal-title":"Mol. Asp. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib44","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1055\/s-2002-35293","article-title":"Pharmacology of recombinant hirudin","volume":"28","author":"Nowak","year":"2002","journal-title":"Semin Thromb. Hemost."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. J. Clin. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2022.112878_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/dna.1.1986.5.511","article-title":"Cloning and expression in Escherichia coli of a synthetic DNA for hirudin, the blood coagulation inhibitor in the leech","volume":"5","author":"Fortkamp","year":"1986","journal-title":"DNA"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10529-011-0740-3","article-title":"Extracellular secretion of anticoagulant peptide hirudin in Lactococcus lactis using SP310mut2 signal peptide","volume":"34","author":"Lv","year":"2012","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib48","doi-asserted-by":"crossref","first-page":"19818","DOI":"10.1038\/s41598-020-76715-w","article-title":"Cell-free synthesis of the hirudin variant 1 of the blood-sucking leech Hirudo medicinalis","volume":"10","author":"W\u00fcstenhagen","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/euhj.2001.2731","article-title":"Efficacy of hirudin in reducing cardiovascular events in patients with acute coronary syndrome undergoing early percutaneous coronary intervention","volume":"23","author":"Mehta","year":"2002","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.7150\/ijms.52752","article-title":"The efficacy and safety of Hirudin plus Aspirin versus Warfarin in the secondary prevention of cardioembolic stroke due to nonvalvular atrial fibrillation: a multicenter prospective cohort study","volume":"18","author":"Song","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biopha.2022.112878_bib51","article-title":"A novel oncotherapy strategy: direct thrombin inhibitors suppress progression, dissemination and spontaneous metastasis in non-small cell lung cancer","author":"Zhao","year":"2021","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2022.112878_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117779","article-title":"Hirudin reduces nephropathy microangiopathy in STZ-induced diabetes rats by inhibiting endothelial cell migration and angiogenesis","volume":"255","author":"Pang","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2022.112878_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2019.03.001","article-title":"Therapeutic effects of the rhSOD2-Hirudin fusion protein on bleomycin-induced pulmonary fibrosis in mice","volume":"852","author":"Shen","year":"2019","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2022.112878_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.660757","article-title":"Pharmacological activities and mechanisms of hirudin and its derivatives - a review","volume":"12","author":"Junren","year":"2021","journal-title":"Front. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.2011.03916.x","article-title":"Direct thrombin inhibitors","volume":"72","author":"Lee","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrcardio.2012.61","article-title":"Direct thrombin inhibitors in cardiovascular disease","volume":"9","author":"Arsenault","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"issue":"16","key":"10.1016\/j.biopha.2022.112878_bib57","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2174\/1389557519666191015201125","article-title":"The Research Progress of Direct Thrombin Inhibitors","volume":"20","author":"Sun","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib58","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s11096-021-01260-z","article-title":"Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis","volume":"43","author":"Colarossi","year":"2021","journal-title":"Int J. Clin. Pharm."},{"issue":"12","key":"10.1016\/j.biopha.2022.112878_bib59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243409","article-title":"Coronavirus-induced coagulopathy during the course of disease","volume":"15","author":"Friedrich","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib60","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11239-020-02251-z","article-title":"Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection","volume":"51","author":"Mcglynn","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"10.1016\/j.biopha.2022.112878_bib61","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJMoa1706443","article-title":"Bivalirudin versus heparin monotherapy in myocardial infarction","volume":"377","author":"Erlinge","year":"2017","journal-title":"New Engl. J. Med."},{"issue":"14","key":"10.1016\/j.biopha.2022.112878_bib62","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib63","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.26194","article-title":"Comparative effectiveness and safety of anticoagulants for the treatment of heparin-induced thrombocytopenia","volume":"96","author":"Nilius","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biopha.2022.112878_bib64","article-title":"Efficacy of bivalirudin for therapeutic anticoagulation in COVID-19 patients requiring ECMO support","author":"Trigonis","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.biopha.2022.112878_bib65","article-title":"The emerging role of bivalirudin for therapeutic anticoagulation in patients with coronavirus disease 2019 requiring extracorporeal membrane oxygenation support: is it time to change the routine practice?","author":"Tahan","year":"2021","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib66","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/CCM.0000000000004944","article-title":"Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: heparin versus bivalirudin","volume":"49","author":"Rivosecchi","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.biopha.2022.112878_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2021.04.035","article-title":"Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26.COV2.S vaccination","volume":"78","author":"Clark","year":"2021","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.112878_bib69","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2022.112878_bib70","article-title":"Net clinical benefit of a reduced dose of DOACs in non-valvular atrial fibrillation: A meta-analysis of randomized trials","author":"Thomopoulos","year":"2021","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ehjcvp\/pvz086","article-title":"Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study","volume":"6","author":"Rutherford","year":"2020","journal-title":"Eur. Heart J. -Cardiovasc. Pharmacother."},{"issue":"12","key":"10.1016\/j.biopha.2022.112878_bib72","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"New Engl. J. Med."},{"issue":"10","key":"10.1016\/j.biopha.2022.112878_bib73","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"New Engl. J. Med."},{"issue":"11","key":"10.1016\/j.biopha.2022.112878_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"New Engl. J. Med."},{"issue":"22","key":"10.1016\/j.biopha.2022.112878_bib75","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jjcc.2021.08.026","article-title":"Venous thromboembolism: recent advancement and future perspective","volume":"79","author":"Yamashita","year":"2022","journal-title":"J. Cardiol."},{"issue":"10264","key":"10.1016\/j.biopha.2022.112878_bib77","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib78","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/joim.13140","article-title":"Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study","volume":"289","author":"Lip","year":"2021","journal-title":"J. Intern. Med."},{"issue":"12","key":"10.1016\/j.biopha.2022.112878_bib79","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.clinthera.2021.09.021","article-title":"Real-world anticoagulant use and incidence of venous thromboembolism and major bleeding in children","volume":"43","author":"Hardin","year":"2021","journal-title":"Clin. Ther."},{"issue":"8","key":"10.1016\/j.biopha.2022.112878_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201377","article-title":"Reversible covalent direct thrombin inhibitors","volume":"13","author":"Sivaraja","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.112878_bib81","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2020.04.020","article-title":"VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis","volume":"190","author":"Sivaraja","year":"2020","journal-title":"Thromb. Res"},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib82","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/jth.15126","article-title":"New anticoagulants: Moving beyond the direct oral anticoagulants","volume":"19","author":"Fredenburgh","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib83","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/a-1384-3715","article-title":"Factor XI as a target for new anticoagulants","volume":"41","author":"Fredenburgh","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.biopha.2022.112878_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.637005","article-title":"Thrombosis: grand challenges ahead!","volume":"8","author":"Ten Cate","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib85","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa2105872","article-title":"Abelacimab for prevention of venous thromboembolism","volume":"385","author":"Verhamme","year":"2021","journal-title":"New Engl. J. Med."},{"issue":"40","key":"10.1016\/j.biopha.2022.112878_bib86","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/eurheartj\/ehab590","article-title":"Abelacimab and factor XI inhibition: a novel mechanism for the prevention of venous thromboembolism","volume":"42","author":"Narducci","year":"2021","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.biopha.2022.112878_bib87","first-page":"770","article-title":"Protein profiling of the medicinal leech salivary gland secretion by proteomic analytical methods","volume":"69","author":"Baskova","year":"2004","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.biopha.2022.112878_bib88","first-page":"261","article-title":"Time to change theory; medical leech from a molecular medicine perspective leech salivary proteins playing a potential role in medicine","volume":"11","author":"Shakouri","year":"2021","journal-title":"Adv. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.biopha.2022.112878_bib89","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaim.2018.09.003","article-title":"Medical leech therapy in ayurveda and biomedicine - a review","volume":"11","author":"Singh","year":"2020","journal-title":"J. Ayurveda Integr. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.112878_bib90","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00438-015-1100-0","article-title":"More than just one: multiplicity of Hirudins and Hirudin-like Factors in the Medicinal Leech, Hirudo medicinalis","volume":"291","author":"M\u00fcller","year":"2016","journal-title":"Mol. Genet. Genom."},{"issue":"6","key":"10.1016\/j.biopha.2022.112878_bib91","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00436-020-06697-1","article-title":"The hirudin-like factors HLF3 and HLF4-hidden hirudins of European medicinal leeches","volume":"119","author":"M\u00fcller","year":"2020","journal-title":"Parasitol. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:23:04Z","timestamp":1774250584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":91,"alternative-id":["S0753332222002670"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112878","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From ancient leech to direct thrombin inhibitors and beyond: New from old","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.112878","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112878"}}